2-Hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-3-(4-(trifluoromethyl)phenyl sulfonyl)propanamide

ID: ALA4541556

PubChem CID: 155551497

Max Phase: Preclinical

Molecular Formula: C18H14F6N2O6S

Molecular Weight: 500.37

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(O)(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C18H14F6N2O6S/c1-16(28,9-33(31,32)12-5-2-10(3-6-12)17(19,20)21)15(27)25-11-4-7-14(26(29)30)13(8-11)18(22,23)24/h2-8,28H,9H2,1H3,(H,25,27)

Standard InChI Key:  MGXFOLLDXHFBKO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 34  0  0  0  0  0  0  0  0999 V2000
   16.0127  -20.8545    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6044  -20.1419    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.1915  -20.8518    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.1821  -18.9085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1810  -19.7360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8958  -20.1488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6123  -19.7355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6094  -18.9049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8941  -18.4958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4662  -20.1479    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7521  -19.7347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0373  -20.1468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7527  -18.9098    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3231  -19.7336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7113  -20.7590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4696  -20.7590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8941  -19.7325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8944  -18.9148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1849  -18.5054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4743  -18.9159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4775  -19.7399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1876  -20.1455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3274  -20.1469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3287  -20.9719    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.0412  -19.7332    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.0378  -20.5586    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.3245  -18.4883    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.3214  -17.6633    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0405  -18.8981    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7590  -18.5048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7573  -17.6798    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.0454  -18.9188    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.0418  -18.0919    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  4  2  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14  2  1  0
 12 15  1  0
 12 16  1  0
  2 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  7 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
 27 28  2  0
 27 29  1  0
  8 27  1  0
 20 30  1  0
 30 31  1  0
 30 32  1  0
 30 33  1  0
M  CHG  2  27   1  29  -1
M  END

Alternative Forms

  1. Parent:

    ALA4541556

    ---

Associated Targets(Human)

CWR22R (2180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VCaP (1078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 500.37Molecular Weight (Monoisotopic): 500.0477AlogP: 3.80#Rotatable Bonds: 6
Polar Surface Area: 126.61Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.52CX Basic pKa: CX LogP: 3.53CX LogD: 3.53
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.35Np Likeness Score: -1.32

References

1. Bassetto M, Ferla S, Pertusati F, Kandil S, Westwell AD, Brancale A, McGuigan C..  (2016)  Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer.,  118  [PMID:27131065] [10.1016/j.ejmech.2016.04.052]

Source